Wednesday, May 15, 2019

Vertex to pay Cambridge startup Kymera $70m in R&D deal - The Boston Globe

Vertex to pay Cambridge startup Kymera $70m in R&D deal  The Boston Globe

Vertex Pharmaceuticals, the Boston biotech best known for its portfolio of drugs to treat cystic fibrosis, will pay $70 million up front to a Cambridge startup that ...



No comments:

Post a Comment